Trade HAE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Haemonetics Corporation (HAE) is trading at US$102.84, down 0.08% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$4.95B. Over the past 52 weeks, HAE has traded between US$47.32 and US$109.57. On Syfe you can trade HAE with $0 commission and add it to your watchlist.
| Previous close | US$102.92 |
|---|---|
| Market cap | US$4.95B |
| P/E ratio | 18.73 |
| 52-week range | US$47.32 – US$109.57 |
| Volume | 581.18K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Haemonetics Corporation
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Year: 1991
Haemonetics Corporation (HAE) stock is trading at US$102.84, -0.08% from the previous close of US$102.92.
The market cap for Haemonetics Corporation (HAE) stock is approximately US$4.95B.
The price-to-earnings ratio for Haemonetics Corporation (HAE) is 18.73, based on the latest reported earnings.
The 52-week high for Haemonetics Corporation (HAE) stock is US$109.57.
The 52-week low for Haemonetics Corporation (HAE) stock is US$47.32.
Haemonetics Corporation (HAE) does not currently pay a dividend.
Stay on top of HAE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
